Not applicableNot Yet RecruitingNCT07393464What this trial is testingPQQ for Cognitive and Negative SymptomsWho this might be right forSchizophreniaCognitive SymptomsNegative Symptoms Tianjin Anding Hospital 70
Post-approval studies (Phase 4)Study completedNCT01246232What this trial is testingAmisulpride Augmentation in Clozapine-unresponsive SchizophreniaWho this might be right forSchizophrenia Imperial College London 69
Not applicableStudy completedNCT01133587What this trial is testingPatient Guided Psychiatric AdmissionsWho this might be right forSchizophreniaBipolar Disorder St. Olavs Hospital 53
Testing effectiveness (Phase 2)Ended earlyNCT01568216What this trial is testing20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsWho this might be right forSchizophrenia Amgen 121
Early research (Phase 1)Study completedNCT01074632What this trial is testingEffect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HClWho this might be right forSchizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder Sumitomo Pharma America, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01354132What this trial is testingN-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum PsychosisWho this might be right forSchizophrenic Psychoses Beth Israel Deaconess Medical Center 20
Not applicableStudy completedNCT00161057What this trial is testingFunctional Brain Activation Patterns in Schizophrenia, Measured Before and After TreatmentWho this might be right forSchizophreniaSchizophreniform Disorders UMC Utrecht 78
Not applicableStudy completedNCT04590300What this trial is testingImpact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education ProgramsWho this might be right forSchizophreniaBipolar Disorder Centre Hospitalier Charles Perrens, Bordeaux 108
Testing effectiveness (Phase 2)UnknownNCT06387771What this trial is testingEvaluation of Tolcapone as a Cognitive Enhancer in SchizophreniaWho this might be right forSchizophrenia Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableActive Not RecruitingNCT05337904What this trial is testingDeep Brain Stimulation Recovery in Treatment-Resistant SchizophreniaWho this might be right forTreatment-resistant SchizophreniaDeep Brain Stimulation Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 6
Large-scale testing (Phase 3)Study completedNCT00101634What this trial is testingEfficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518
Not applicableStudy completedNCT03826563What this trial is testingMelatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk SymptomsWho this might be right forPsychosisSleep Children's Hospital of Philadelphia 21
Testing effectiveness (Phase 2)Study completedNCT01450514What this trial is testingPOC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaWho this might be right forChronic SchizophreniaSchizoaffective Disorder PharmaNeuroBoost N.V. 7
Not applicableUnknownNCT02850445What this trial is testingTrial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia InpatientsWho this might be right forSchizophrenia Guangzhou Psychiatric Hospital 170
Not applicableStudy completedNCT03959735What this trial is testingHigh Intensity Interval Training in Severe Mental IllnessWho this might be right forMajor Depressive DisorderBipolar DisorderSchizophrenia King's College London 19
Not applicableUnknownNCT02378818What this trial is testingCharacterization of the Motivational Deficit in Schizophrenia and DepressionWho this might be right forSchizophreniaDepression Centre Hospitalier St Anne 140
Not applicableEnded earlyNCT00211380What this trial is testingCognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)Who this might be right forSchizophreniaSchizoaffective Disorder Louisiana State University Health Sciences Center Shreveport 8
Testing effectiveness (Phase 2)Ended earlyNCT02088060What this trial is testingA Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic PatientsWho this might be right forSchizophrenia Central Institute of Mental Health, Mannheim 150
Testing effectiveness (Phase 2)Study completedNCT01086748What this trial is testingA Comparator Study of LY2140023 Versus Placebo in Schizophrenia PatientsWho this might be right forSchizophrenia Denovo Biopharma LLC 1,134
Large-scale testing (Phase 3)Study completedNCT03510325What this trial is testingSequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)Who this might be right forSchizophrenia Shanghai Mental Health Center 762